A Clinical Trial for the Treatment of Depression With Repetitive Transcranial Magnetic Stimulation (rTMS)

Completed · Not applicable · Has a placebo group

Conditions studied: Depressive Disorder, Major

In brief

The purpose of this study is to determine whether the Cervel Neurotech rTMS device is safe and effective in the treatment of depression in people who do not get better with antidepressant medications or cannot take antidepressant medications.

Key facts

Study ID
NCT01909232
Run by
Cervel Neurotech, Inc.
People needed
92
Starts
2013-07-01
Expected to finish
2014-07-01
Last updated by the study team
2016-07-28

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.